期刊文献+

非索那丁治疗慢性特发性荨麻疹临床研究 被引量:1

Clinical study on the efficacy and safety of fexofenadine in the treatment of chronic indiopathic urticaria
暂未订购
导出
摘要 目的 了解盐酸非索那丁片治疗慢性特发性荨麻疹的临床有效性和安全性。 方法 采用多中心、随机、双盲、平行对照的方法 ,试验组药品为盐酸非索那丁片 ,180mg/d ;对照组药品为氯雷他啶片 ,10mg/d ,两药均为每日口服 1次、疗程 14d。 结果 完成治疗 12 2例 ,揭盲后显示试验组 60例 ,对照组 62例。试验组有效率为 71 7% (4 3 /60 ) ,对照组有效率为 5 0 0 % (3 1/ 62 ) ,两组疗效比较有统计学差异 ;12 8例入选病例中 9例出现不良反应 ,发生率试验组为 7 9% (5 / 63 ) ,对照组为 6 2 % (4 / 65 ) ,两组间无差别 ,无严重不良反应发生。 结论 盐酸非索那丁片是一种治疗慢性特发性荨麻疹安全、有效的药物。 Objective To observe the clinical efficacy and safety of fexofenadine hydrochloride in the treatment of chronic idiopathic urticaris(CIU) Methods A multicenter,randomized,double blind,parallel controlled clinical study was conducted The patients with CIU received orally either fexofenadine hydrochloride 180mg (test group) or loratadine 10mg(control group) once daily for 14 days Results A total of 122 patients with CIU were treated completely,of which 60 cases were in the test group,62 in the control group The effective rate in the test group was 71 7%(43/60),and in the control group 50 0%(31/62),there was a statistically significant difference between the two groups The adverse effects occurred in 9 cases of the 128 enrolled patients,and the incidence was 7 9%(5/63) in the test group,6 2%(4/65) in the control group,there was no statistical difference between the two groups Severe adverse effect was not observed Conclusion Fexofenadine hydrochloride is safe and effective for the treatment of CIU
出处 《中国热带医学》 CAS 2004年第2期162-164,共3页 China Tropical Medicine
  • 相关文献

参考文献5

  • 1[1]Simpson K,Jarvis B.Fexofenadne:a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria[J]. Drugs,2000,59(2):301 ~ 321.
  • 2[2]Bunnag C,Jareoncharsri P,Tunsuriyawong P,et al.A non-comparative trial of the efficacy and safety of fexofenadine for treatment of perennial allergic rhinitis[J].Asian Pac J Allergy Immunol,2000,18(3):127-133.
  • 3[3]Nelson HS, Reynolds R,Masson J.Fexofenadine HCI is safe and effctive for treatment of chronic idiopathic urticaris[J].Ann AllergyImmunol.2000,84(5):517 ~ 522.
  • 4[4]Hindmarch I,Shamsi Z,Kimber S.An evaluation of the efects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteer[J] .Clin Exp Allergy,2002,32(1): 133~ 139.
  • 5[5]Mason J, Reynolds R,Rao N.The systemic safety of fexofenadine HCI[J].Clin Exp Allergy,1999,29(3):163 ~ 170.

同被引文献8

  • 1荨麻疹诊疗指南(2007版)[J].中华皮肤科杂志,2007,40(10):591-593. 被引量:216
  • 2Penders J, Stobberingh EE, van den Brandt PA, et al. The role of the intestinal microbiota in the development of atopic disorders [J]. Allergy, 2007,62( 11 ) : 1223-1236.
  • 3Ozdemir O. Various effects of different probiotic strains in allergic disorders:an update from laboratory and clinical data [J]. Clin Exp Immunol, 2010,160(3) :295-304.
  • 4Rautava S, Arvilommi H, Isolauri E. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants[J]. Pediatr Res, 2006,60(2) : 221-224.
  • 5Borchers AT, Selmi C, Meyers F J, et al. Probiotics and immunity [ J ]. J Gastroenterol, 2009,44( 1 ) : 26-46.
  • 6Cabana MD,McKean M,Wong AR,et al . Examining the hygiene hypothesis : the Trial of Infant Probiotic Supplementation[ J ]. Paediatr Perinat Epidemiol,2007 Nov;21 Suppl 3:23-28.
  • 7蔚京京,邵洁,李云珠,俞善昌,夏振炜.meta分析:益生菌在防治儿童特应性皮炎中的作用[J].临床儿科杂志,2008,26(5):433-437. 被引量:15
  • 8陈英,逯军,甘英文.口服益生菌预防早产儿真菌感染的疗效[J].中国热带医学,2008,8(9):1575-1575. 被引量:7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部